Loading...

Alterola Biotech, Inc.

ABTIPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Alterola Biotech, Inc. (ABTI) Stock Competitors & Peer Comparison

See (ABTI) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ABTI$0.00+0.00%291.9K-0.02-$0.01N/A
MKGAF$124.50-2.83%55.5B17.25$7.40+2.08%
MKKGY$24.69-1.52%54.2B16.63$1.50+2.03%
TKPHF$27.50+0.00%43B47.41$0.58+4.84%
HLNCF$4.62-0.86%41.5B21.98$0.21+1.87%
IPSEY$30.05-6.73%40.7B19.71$1.56+0.81%
SDZNY$55.91-1.52%24.1B-2797.00-$0.02+1.21%
ESALY$61.51-2.11%17.6B20.54$3.00N/A
TEVJF$14.00+0.00%16.1B-93.33-$0.15N/A
SGIOY$8.87+1.49%15.1B13.04$0.68+1.80%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ABTI vs MKGAF Comparison August 2025

ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ABTI stands at 291.9K. In comparison, MKGAF has a market cap of 55.5B. Regarding current trading prices, ABTI is priced at $0.00, while MKGAF trades at $124.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ABTI currently has a P/E ratio of -0.02, whereas MKGAF's P/E ratio is 17.25. In terms of profitability, ABTI's ROE is -0.15%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ABTI is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check MKGAF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;